Prospective Randomized Trial of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease (SORT OUT IV trial) - 3-year follow up.

Activity: Talks and presentationsTalks and presentations in private or public companies

Period2012 → …
Held atUnknown external organisation, Unknown